Software Daily Summary
Software Daily Summary: What Happened on November 9, 2026
AI protein designs bind targets, while neuroscience agents miss most benchmark tasks
Today’s software news also included a Duke–Network Bio partnership to build disease models from biological and clinical data.
-
L
Today in brief
Anthropic’s AI-designed minibinders bound targets in lab tests, but only 354 of 1,320 tested designs worked.1 Separately, Latch Bio’s neuroscience benchmark found that the best-performing AI agent configuration passed 32.2% of its evaluations.2
Also worth knowing
-
Network Bio and Duke University will build AI disease models using molecular profiles from biobank samples combined with anonymized patient records and treatment outcomes.3
Also published
- AI Can Draft the CSR Faster, But Does That Make Drug Development Faster? Applied Clinical Trials
- ChemDoodle 3D updated Mac in Chem
- Single Partner Platforms: Enhancing the Prescription Journey for Manufacturers Pharmaceutical Executive
- More on web browser extensions Mac in Chem
- The growing use of synthetic data in modern pharma pharmaphorum
- This Week In Cheminformatics: Issue #046 This Week in Cheminformatics
- AI beats scientists at finding errors in clinical research papers Science News